Edit
Longevity Venture Partners
https://www.longevityventurepartners.comLast activity: 11.07.2026
Active
Longevity Venture Partners is an early-stage venture capital firm committed to assisting entrepreneurs in the Silvertech, Healthcare, and Wellness sectors.
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 18
| Date | Name | Website | Total Raised | Location |
| 10.07.2026 | CustoMED t... | customed.ai | - | - |
| 10.07.2026 | Urologic H... | urologic.health | - | - |
| 10.07.2026 | Sensifai H... | sensifai.health | - | Canada |
| 10.07.2026 | Lembas | hellolembas.com | - | - |
| 10.07.2026 | ActualSign... | actualsignal.com | - | - |
| 10.07.2026 | Carefam | carefam.com | $14.5M | United Sta... |
| - | Brya | brya.com | - | - |
| - | Carefull | getcarefull.com | $19.7M | United Sta... |
| - | Voxela | voxela.ai | - | United Sta... |
| - | FertilAi | fertilai.com | $4.5M | - |
Show more
Mentions in press and media 9
| Date | Title | Description |
| 14.05.2026 | Urologic Health Secures $11M for Non-Invasive Bladder Function Monitoring | What You Should Know Urologic Health Inc. has closed an $11M seed financing round led by an undisclosed strategic investor, with participation from Edge Medical Ventures, SHD Partners, and Longevity Venture Partners. The funding supports cl... |
| 31.10.2025 | CustoMED Expands Global Reach with $6M Investment in AI-Driven Orthopedic Care | Israeli healthtech company CustoMED has completed its seed funding round, bringing total funding to $6 million. The round includes participation from Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority,... |
| 29.10.2025 | CustoMED Secures $6M to Scale AI-Driven, Patient-Specific Orthopedic Surgery | What You Should Know: – CustoMED, a pioneer in AI-driven, surgeon-first platforms for patient-specific orthopedic solutions, announced the successful completion of its seed round, bringing total funding to $6M. – The investment round includ... |
| 10.06.2025 | ‘Pharma is eating Big Food’s lunch…’ Lembas fights back with GLP-1 boosting peptide | Israeli foodtech startup Lembas has emerged from stealth with “GLP-1 Edge,” a bioactive peptide that triggers the production of GLP-1 and other gut hormones that regulate appetite and metabolism. Founded in 2024 by Shay Hilel (CEO), Dr. Zoh... |
| 11.05.2024 | In-House Health Transforms Nurse Scheduling Landscape with Cutting-Edge AI Technology | In a groundbreaking move that is set to revolutionize the way nurse scheduling is managed, In-House Health, a Denver-based healthcare technology company, recently announced the successful completion of a $4 million Seed funding round. Spear... |
| 08.05.2024 | In-House Health Launches AI-Powered Scheduling Platform for Nursing with $5.4M in Funding | What You Should Know: – In-House Health, a healthcare technology company focused on streamlining nurse scheduling, announced its official launch and $5.4 million in funding. – The investment round, led by NEA and TMV with participation from... |
| 24.03.2023 | Longevity Venture Partners Raises $30 Million Fund to Advance Aging-in-Place and Longevity Solutions | JERUSALEM, ISRAEL, March 24, 2023/EINPresswire.com/ -- Longevity Venture Partners (LVP), a venture capital firm focused on investing in companies that develop technologies and solutions to support the aging population, announced today the c... |
| 23.09.2022 | Voxela, Developer of Next-Generation Eldercare Solutions, raised a seed round from the U.S and Japanese venture capital firms specializing in aging technologies | SAN FRANCISCO (PRWEB) September 23, 2022 Voxela was founded in Silicon Valley as a company that uses vision AI to create a comprehensive, personalized database of movements and activities. The company has already developed solutions to dete... |
| 10.03.2022 | Behavidence Closes $4.3 Million Seed Round to Amplify its Artificial Intelligence Technology used to Detect, Screen and Monitor Mental Illness | Today’s funding announcement demonstrates our investors’ support, commitment, and optimism for the future of Behavidence NEW YORK (PRWEB) March 10, 2022 Behavidence, a leading startup company that monitors psychiatric and neurological disor... |